Zealand’s New CEO Emphasizes Her Market Access, Pricing Experience
This article was originally published in The Pink Sheet Daily
Executive Summary
Recently appointed chief exec Britt Meelby Jensen said in an interview that she is poised to lead the developer of innovative peptide drugs into its next phase of operation – getting to market.